This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
BEFORE the development of genetic engineering technologies, it was questionable whether microorganisms that theoretically could be produced by application of such techniques would legally qualify for patent protection.
Section 101 of the Patent Act, 35 USC §101 (1976), authorizes the Commissioner of Patents and Trademarks to issue a patent to one who "invents or discovers any new and useful process... manufacture, or composition of matter." In Funk Brothers Seed Co v Kalo Inoculent Co, 333 US 127 (1948), the US Supreme Court had held that nonengineered microorganisms were "products of nature," and not subject to patent claims of one who "discovers" them as naturally occurring. Patents had been issued for the application of microorganisms to produce chemicals such as antibiotics and agents to remove environmental pollutants—uses patentable as "processes" within the terms of the Patent Act—but the US Patent and Trademark Office had rejected patent claims to the microorganisms themselves.
Cooper A. Patentability of Genetically Engineered Microorganisms. JAMA. 1983;249(12):1553–1554. doi:10.1001/jama.1983.03330360015008
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.